@article{CCO25149,
author = {Adam Garsa and Jennifer C. Ho and Chaosu Hu and Eric L. Chang},
title = {Bevacizumab is more effective in nasopharyngeal carcinoma patients with lower maximum radiation dose to the temporal lobe},
journal = {Chinese Clinical Oncology},
volume = {8},
number = {Suppl 1},
year = {2019},
keywords = {},
abstract = {Nasopharyngeal carcinoma (NPC), due to its location and routes of spread, requires radiation therapy to the skull base and may include a portion of the temporal lobes of the brain in the high dose volume by virtue of its anatomic location. Radiation-induced brain necrosis (RN) usually develops months to years after radiation therapy.},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/25149}
}